BrainsWay Investor Relations Material
Latest events
Q3 2024
BrainsWay
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from BrainsWay Ltd
Access all reports
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company offers Deep TMS device that uses magnetic current pulses to stimulate the brain safely and painlessly; and Deep TMS Coil that is attached to the dTMS device. It markets the BrainsWay Deep TMS system under the hElios brand name for treating various psychiatric and neurological disorders. Brainsway Ltd. has a license agreement with InSightec, Ltd., which is a co-owner of the exclusive license issued by the Technion-Israel Institute of Technology. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BWAY
Country
πΊπΈ United States